General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Investor relations contacts

For all other queries:

Main Switchboard
Switzerland
+41 61 324 11 11

US switchboard

+1 862 778 21 00

Email address:
Samir Shah
Global Head Investor Relations
+41 61 324 79 44
Pierre-Michel Bringer +41 61 324 10 65
Thomas Hungerb├╝hler +41 61 324 84 25
Isabella Zinck +41 61 324 71 88
Mailing address:

Novartis International AG
Investor Relations
P.O. Box
CH - 4002 Basel / Switzerland

+41 61 324 79 44

+41 61 324 84 44

Stock chart
Q3 Results 2013

On Thursday, April 24, Novartis will announce its results for the first quarter of 2014